porcin
reproduct
respiratori
syndrom
prr
respiratori
diseas
pig
age
reproduct
diseas
sow
prr
endem
diseas
swine
industri
worldwid
caus
approxim
million
loss
annual
usa
prr
viru
prrsv
caus
agent
isol
simultan
europ
north
america
prrsv
belong
arterivirida
famili
display
high
genet
divers
control
prr
modifi
liveattenu
prr
vaccin
prrsmlv
wide
use
sinc
prrsmlv
protect
pig
clinic
diseas
reduc
lung
lesion
viral
shed
elicit
protect
respons
homolog
viru
apart
concern
safeti
prrsmlv
vaccin
pig
breadth
crossprotect
induc
mlv
highli
question
adjuv
necessari
potenti
vaccin
efficaci
vaccin
inocul
mucos
site
along
potent
adjuv
upregul
express
costimulatori
molecul
immun
cell
secret
chemokin
cytokin
mucos
vaccin
coadminist
potent
adjuv
induc
superior
crossprotect
immun
enhanc
array
antigen
specif
b
cell
respons
mediat
dramat
increas
spread
antigen
epitop
recognit
multipl
conserv
epitop
otherwis
recogn
thu
potenc
adjuv
deliveri
system
determin
degre
crossprotect
prrsv
caus
diseas
primarili
respiratori
tract
thu
intranas
deliveri
prrsmlv
potent
adjuv
promis
demonstr
pig
vaccin
prrsmlv
intranas
potent
adjuv
mycobacterium
tuberculosi
whole
cell
lysat
tb
wcl
elicit
better
crossprotect
immun
respons
heterolog
challeng
without
adjuv
largescal
product
tb
wcl
involv
risk
time
cost
tb
biosafeti
level
bsl
agent
altern
nonpathogen
mycobacterium
vacca
adjuv
shown
stimul
cytotox
tcell
respons
provid
protect
respons
tuberculosi
anoth
vaccin
adjuv
cpgoligodeoxynucleotid
cpgodn
activ
profession
antigenpres
cell
potenti
antibodi
crossreact
cell
respons
mice
pig
therefor
studi
evalu
crossprotect
efficaci
prrsmlv
coadminist
adjuv
vacca
wcl
cpg
odn
im
rout
result
suggest
two
adjuv
potent
enough
augment
breadth
immun
prr
rather
prrsmlv
deliv
im
without
adjuv
rel
better
result
suggest
studi
requir
improv
crossprotect
efficaci
prrsmlv
use
highli
potent
adjuv
deliv
im
cell
use
grow
prrsv
immunolog
assay
cell
maintain
high
glucos
dmem
hyclon
usa
supplement
mm
hepe
fisher
scientif
nj
usa
antibioticantimycot
solut
hyclon
ut
usa
fb
atlanta
biolog
ga
usa
humidifi
atmospher
dmem
contain
fb
use
grow
viru
cell
prrsmlv
provid
boehring
field
prrsv
strain
isol
infect
sow
ohio
use
challeng
pig
prrsmlv
parent
strain
genet
variant
type
prrsv
strain
use
analyz
viru
specif
neutral
antibodi
na
titer
plasma
bal
fluid
sampl
prrsv
nucleotid
sequenc
similar
vaccin
strain
challeng
stain
prrsv
propag
cell
aliquot
store
use
mycobacterium
vacca
atcc
grown
endotoxin
free
medium
accord
atcc
instruct
whole
cell
lysat
wcl
prepar
previous
describ
cpg
odn
tcgtcgttgtcgttttgtcgtt
phosphorothio
backbon
custom
prepar
integr
dna
technolog
ia
usa
five
conserv
cell
peptid
prrsv
aa
cpgknsfldeaaycnhl
aa
vrilaggwcpgknsfld
aa
vrgnpervkgvlqntrf
aa
kgrlyrwrspviiek
n
aa
vrhhftpse
custom
synthes
thermofish
scientif
ny
usa
total
convent
larg
whiteduroc
crossbr
week
old
pig
procur
ohio
state
univers
swine
herd
seroneg
prrsv
porcin
respiratori
coronaviru
transmiss
gastroenter
viru
porcin
circoviru
pig
allow
acclim
week
initi
experi
randomli
divid
six
group
n
per
group
figur
anim
maintain
food
water
ad
libitum
larg
anim
facil
supervis
veterinarian
adjuv
vacca
wcl
mgpig
cpgodn
prrsmlv
vaccin
dose
per
manufactur
recommend
inocul
either
im
rout
mix
inocul
pig
inocul
separ
either
side
neck
im
nostril
mist
pig
group
vaccin
intranas
prrsmlv
without
adjuv
includ
studi
group
includ
previou
studi
pig
receiv
ml
vaccin
formul
ml
vaccineadjuv
side
neck
nostril
pig
challeng
use
heterolog
prrsv
strain
per
pig
day
postvaccin
dpv
mist
euthan
day
postchalleng
dpc
figur
rectal
temperatur
bodi
weight
pig
record
experi
day
blood
collect
collect
sampl
mainten
euthan
pig
perform
per
approv
anim
use
care
committe
protocol
ohio
state
univers
evalu
viremia
prrsv
specif
neutral
antibodi
respons
ml
blood
collect
dpv
dpc
plasma
separ
use
edta
plu
blood
collect
tube
bd
vacutain
nj
usa
preserv
use
assay
dpv
dpc
peripher
blood
mononuclear
cell
pbmc
isol
blood
collect
edta
gradient
centrifug
use
lymphoprep
solut
sepmat
tube
stem
cell
technolog
canada
pbmc
resuspend
enrichedrpmi
erpmi
rpmi
contain
fb
hepe
mm
sodium
pyruv
nonessenti
amino
acid
antibiot
antifung
bronchoalveolar
lavag
bal
fluid
collect
necropsi
describ
previous
aliquot
store
use
assay
analysi
prrsv
na
titer
plasma
bal
fluid
perform
indirect
immunofluoresc
assay
ifa
briefli
viru
titrat
confluent
monolay
cell
microtit
plate
treat
dilut
sampl
h
vnt
sampl
heat
min
uv
nm
min
inactiv
use
assay
twofold
serial
dilut
sampl
incub
equal
volum
prrsv
strain
per
well
strain
per
well
h
mixtur
transfer
microtit
plate
contain
confluent
monolay
cell
incub
h
cell
plate
fix
use
acetonemilliq
water
mixtur
min
room
temperatur
dri
plate
treat
antiprrsv
nucleocapsid
protein
specif
monoclon
antibodi
rural
technolog
inc
sd
usa
h
follow
alexa
fluor
conjug
goat
antimous
igg
h
l
invitrogen
ca
usa
secondari
antibodi
plate
examin
fluoresc
microscop
mount
glycerolphosphatebuff
salin
pb
viru
induc
cytopath
effect
examin
fluoresc
microscop
titer
calcul
use
reed
muench
method
prrsv
titer
express
tissu
cultur
infect
dose
per
ml
na
titer
reciproc
dilut
plasma
bal
fluid
caus
reduct
virusspecif
fluoresc
foci
compar
viru
control
well
plasma
bal
fluid
sampl
use
prepar
rna
viral
rna
isol
kit
ambionappli
biosystem
ca
usa
rna
isol
perform
use
sampl
use
express
magnet
particl
processor
appli
biosystem
ny
usa
accord
manufactur
instruct
rna
revers
transcrib
complementari
dna
cdna
use
quantitect
revers
transcript
kit
qiagen
germani
cdna
use
realtim
pcr
reaction
perfecta
sybr
green
fast
mix
quanta
bioscienc
md
usa
use
prrsv
gene
deriv
forward
primer
gataaccacgcatttgtcgtc
revers
primer
tgccgttgttatttggcata
standard
curv
gener
use
serial
dilut
known
copi
pcr
product
prrsv
rna
copi
ml
plasma
bal
fluid
determin
flow
cytometri
analysi
perform
determin
popul
lymphocyt
subset
acquir
event
immunostain
pbmc
briefli
pbmc
isol
dpv
dpc
plate
cellswel
tissu
cultur
plate
presenc
prrsv
strain
moi
pool
five
prrsv
conserv
peptid
peptid
ml
erpmi
h
cell
cultur
erpmi
medium
includ
control
golgistop
protein
transport
inhibitor
bd
bicosci
ca
usa
goldiplug
brefeldin
sigmaaldrich
mo
usa
ad
last
h
incub
cell
first
surfacelabel
use
pig
specif
mab
chain
conjug
differ
fluorochrom
subsequ
cell
fix
permeabil
stain
intracellular
use
fluorochromeconjug
mous
antipig
mab
isotyp
control
mab
bd
bioscienc
ca
usa
immunostain
cell
acquir
use
bd
aria
ii
flow
cytomet
analyz
use
flowjo
softwar
studi
carri
strict
accord
recommend
public
health
servic
polici
unit
state
depart
agricultur
regul
nation
research
council
guid
care
use
laboratori
anim
feder
anim
scienc
societi
guid
care
use
agricultur
anim
agricultur
research
teach
relev
institut
state
feder
regul
polici
follow
regard
care
use
anim
ohio
state
data
express
mean
valu
pig
sem
statist
analys
perform
use
graphpad
prism
softwar
appli
one
way
anova
follow
tukey
ttest
statist
signific
consid
p
although
observ
respiratori
distress
experiment
pig
group
mlvcpg
im
group
mlvcpg
group
pb
pig
moder
fever
dpc
figur
prrsv
titer
rna
load
rna
copiesml
plasma
bal
fluid
determin
qrtpcr
prrsv
use
cell
replic
infecti
viru
titer
respect
plasma
prrsv
rna
copi
group
mlvim
group
mlvcpg
im
group
mlvvac
im
pig
log
higher
compar
group
mlvcpg
group
mlvvac
dpv
log
lower
dpc
compar
group
figur
prechalleng
pig
replic
vaccin
viru
detect
im
vaccin
group
figur
dpc
detect
infecti
viru
im
pig
group
absent
data
statist
signific
compar
pig
group
pb
p
group
mlvcpg
p
figur
replic
viru
undetect
plasma
group
mlvcpg
dpc
dpc
group
pig
figur
bal
fluid
log
viral
rna
copi
detect
pig
group
particular
four
pig
group
pb
group
mlvcpg
high
level
rna
copi
logsml
log
greater
group
figur
replic
viru
absent
bal
fluid
im
pig
group
one
two
pig
vaccin
group
still
infecti
viru
figur
prrsvspecif
na
titer
plasma
bal
fluid
strain
analyz
plasma
na
titer
strain
gradual
increas
pig
group
im
vaccin
group
titer
twofold
higher
vaccin
group
mean
titer
dpc
figur
b
contrast
na
titer
strain
remain
test
pig
group
figur
bal
fluid
na
titer
three
test
viral
strain
pig
group
group
strain
na
titer
figur
popul
cell
thelpermemori
cell
pbmc
group
mlvim
group
mlvvac
im
group
mlvvac
pig
dpv
significantli
increas
compar
group
pb
figur
b
mlvvac
im
pig
group
increas
count
cell
compar
pb
control
figur
popul
cell
significantli
increas
mlvvac
pig
group
restimul
viru
compar
peptid
stimul
dpc
figur
dpv
none
pig
group
increas
activ
lymphocyt
subset
figur
dpc
significantli
increas
popul
total
secret
cell
nk
cell
detect
figur
also
posit
cytotox
cell
ctl
cell
thelpermemori
cell
observ
group
mlvim
pig
restimul
challeng
viru
ex
vivo
compar
control
vaccin
trial
group
figur
restrict
fragment
length
polymorph
rflp
code
type
prototyp
prrsv
strain
deriv
prrsmlv
boehring
passag
repeatedli
cell
becam
avirul
pig
rflp
code
challeng
field
viru
use
studi
wide
preval
north
america
approxim
differ
amino
acid
sequenc
compar
sequenc
thu
analyz
efficaci
prrsmlv
vacca
wcl
cpg
odn
administ
im
genet
heterolog
viral
strain
pig
previous
demonstr
pig
immun
prrsmlv
tb
wcl
elicit
crossprotect
respons
heterolog
prrsv
strain
also
nucleotid
differ
sequenc
compar
studi
result
indic
prrsmlv
im
without
adjuv
receiv
pig
log
reduc
challeng
viral
rna
compar
rout
vaccin
anim
im
vaccin
pig
replic
challeng
viru
absent
dpc
plasma
also
bal
fluid
dpc
immunolog
result
support
na
titer
strain
im
vaccin
pig
data
consist
earlier
studi
wherein
prrsv
na
titer
higher
protect
piglet
develop
viremia
studi
im
vaccin
pig
singl
dose
prrsmlv
partial
protect
heterolog
challeng
viru
similar
degre
partial
protect
observ
heterolog
challeng
studi
use
highli
pathogen
prrsv
strain
deriv
prrsmlv
vaccin
pig
protect
respons
prrsv
prrsmlv
vaccin
pig
found
depend
level
cellmedi
humor
immun
pig
vaccin
intranas
use
prrsmlv
potent
adjuv
tb
wcl
substanti
increas
respons
associ
greater
twofold
increas
popul
doubl
posit
cell
thelpermemori
viruschalleng
pig
pig
vaccin
inactiv
prrsv
deliv
biodegrad
nanoparticl
frequenc
cell
subset
significantli
enhanc
correl
well
clearanc
heterolog
challeng
viru
blood
lung
suggest
strong
associ
prrsv
clearanc
cell
respons
therefor
studi
determin
popul
variou
posit
cell
subset
pig
doubl
posit
cell
shown
possess
memori
helper
phenotyp
upregul
activ
cell
subset
correl
strongli
protect
immun
respons
classic
swine
fever
aujeszki
diseas
prrsv
prrsmlv
without
adjuv
im
receiv
pig
significantli
increas
popul
activ
doubl
posit
cell
observ
addit
pig
bear
cell
either
ctl
cell
cell
phenotyp
exclus
ctl
prrsmlv
im
adjuv
vaccin
pig
enhanc
popul
cell
bear
phenotyp
marker
detect
dpv
activ
cell
detect
viru
challeng
pig
dpc
addit
upregul
nk
cell
popul
observ
recal
activ
lymphocyt
respons
detect
use
challeng
prrsv
pool
conserv
five
peptid
type
prrsv
structur
nonstructur
protein
suggest
studi
test
peptid
may
highli
immunogen
pig
overal
increas
popul
activ
cell
subset
prrsmlv
im
receiv
pig
group
compar
deliveri
observ
howev
due
low
na
titer
im
vaccin
pig
cell
respons
data
alon
may
suggest
heighten
heterolog
protect
respons
rout
vaccin
administr
immunomodul
must
consid
improv
vaccin
immun
aas
et
al
report
im
immun
meningococc
outer
membran
vesicl
human
induc
signific
igg
respons
opsonophagocyt
activ
serum
bactericid
activ
compar
group
immun
vaccin
antigen
induc
persist
mucos
system
antibodi
respons
antibacteri
activ
conclus
identifi
costeffect
potent
adjuv
potent
adjuv
effect
akin
tb
wcl
benefici
use
prrsmlv
im
rout
current
practic
swine
produc
countri
control
prr
inspit
abil
induc
limit
crossprotect
